Authors

Donna Lee Armaignac, Baptist Health South FloridaFollow

Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS)

Publication Date

11-2022

Content Type

Article

PubMed ID:

36153214

Additional Authors:

Additional authors and institutional affiliations

Citation

Lal, A., Garces, J. P. D., Bansal, V., Tekin, A., Zec, S., Khanna, A. K., Warner, M. A., Christie, A. B., Cartin-Ceba, R., Banner-Goodspeed, V. M., Armaignac, D. L., Cheruku, S. R., Raju, U., Tarabichi, Y., Denson, J. L., Kumar, V., Walkey, A., Boman, K., Deo, N., Kashyap, R., … from the Society of Critical Care Medicine Discovery Viral Infection, Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group (2022). Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS). Archivos de bronconeumologia, 58(11), 746–753. https://doi.org/10.1016/j.arbres.2022.07.017